Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid

被引:29
|
作者
Chiorean, Roxana [1 ,2 ]
Danescu, Sorina [2 ]
Virtic, Oana [1 ]
Mustafa, Mayson B. [1 ]
Baican, Adrian [2 ]
Lischka, Annette [1 ]
Hashimoto, Takashi [3 ]
Kariya, Yoshinobu [4 ]
Koch, Manuel [5 ,6 ]
Sitaru, Cassian [1 ]
机构
[1] Univ Med Ctr Freiburg, Dept Dermatol, Hauptstr 7, D-79104 Freiburg, Germany
[2] Univ Med & Pharm Iuliu Hatieganu, Dept Dermatol, Cluj Napoca, Romania
[3] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan
[4] Fukushima Med Univ, Dept Biochem, Fukushima, Japan
[5] Univ Cologne, Inst Dent Res & Oral Musculoskeletal Biol, Cologne, Germany
[6] Univ Cologne, Med Fac, Ctr Biochem, Cologne, Germany
来源
关键词
Autoantibody; Autoimmunity; Autoantigen; ELISA; Extracellular matrix; Immunoassay; Immunobloting; EPIDERMOLYSIS-BULLOSA-ACQUISITA; AUTOIMMUNE SKIN DISEASES; SUBEPIDERMAL BLISTERS; NEONATAL MICE; AUTOANTIBODIES; TARGET; IGG; GLYCOSYLATION; ANTIGEN-180; PROTEIN;
D O I
10.1186/s13023-018-0855-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Mucous membrane pemphigoid is a group of chronic subepithelial autoimmune blistering diseases that mainly affect mucous membranes. Laminin 332-specific autoantibodies are present in approximately 1/3 of the patients, being associated with an increased risk of malignancy. Because of the severe complications, an early recognition of the disease allowing a timely therapy is essential. The gold standard methods for detection of laminin 332-specific autoantibodies, including the immunoprecipitation and immunoblotting are non-quantitative, laborious and restricted to a few specialized laboratories worldwide. In addition, the use of radioimmunoassays, although highly sensitive and specific, are laborious, expensive and tightly regulated. Therefore, there is a stringent need for a quantitative immunoassay for the routine detection of laminin 332-specific autoantibodies more broadly available to diagnostic laboratories. The aim of this study was to compare different antigenic substrates, including native, recombinant laminin 332 and laminin 332-rich keratinocyte extracellular matrix, for development of an ELISA to detect autoantibodies in mucous membrane pemphigoid. Results: Using a relatively large number of sera from MMP patients with well-characterized autoantibody reactivity we show the suitability of ELISA systems using laminin 332 preparations as adjunct diagnostic tools in MMP. While glycosylation of laminin 332 does not appear to influence its recognition by MMP autoantibodies, ELISA systems using both purified, native and recombinant laminin 332 demonstrated a high sensitivity and good correlation with the detection of autoantibodies by immunoblotting. ELISA systems using different laminin 332 preparations represent a feasible and more accessible alternative for a broad range of laboratories. Conclusions: Our findings qualify the use of immunoassays with the laminin 332-rich preparations as an ancillary diagnostic tool in mucous membrane pemphigoid.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid
    Roxana Chiorean
    Sorina Danescu
    Oana Virtic
    Mayson B. Mustafa
    Adrian Baican
    Annette Lischka
    Takashi Hashimoto
    Yoshinobu Kariya
    Manuel Koch
    Cassian Sitaru
    Orphanet Journal of Rare Diseases, 13
  • [2] Anti-Laminin 332-Type Mucous Membrane Pemphigoid
    Shi, Luhuai
    Li, Xiaoguang
    Qian, Hua
    BIOMOLECULES, 2022, 12 (10)
  • [3] Sensitive and specific assay for the serological diagnosis of anti-laminin 332 mucous membrane pemphigoid
    Goletz, S.
    Probst, C.
    Komorowski, L.
    Schlumberger, W.
    van Beek, N.
    Holtsche, M. M.
    Recke, A.
    Yancey, K. B.
    Hashimoto, T.
    Antonicelli, F.
    Di Zenzo, G.
    Zillikens, D.
    Stoecker, W.
    Schmidt, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S15 - S15
  • [4] Sensitive and specific assay for the serological diagnosis of anti-laminin 332 mucous membrane pemphigoid
    Goletz, S.
    Probst, C.
    Komorowski, L.
    Schlumberger, W.
    van Beek, N.
    Dieterich, A.
    Recke, A.
    Yancey, K. B.
    Hashimoto, T.
    Antonicelli, F.
    Di Zenzo, G. M.
    Zillikens, D.
    Stocker, W.
    Schmidt, E.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E51 - E51
  • [5] Comparison of two tools for the serological diagnosis of anti-laminin 332 mucous membrane pemphigoid
    Goletz, S.
    Giurdanella, F.
    Hubner, F.
    Nijenhuis, M.
    Horvath, B.
    Diercks, G.
    Hashimoto, T.
    Zillikens, D.
    Schmidt, E.
    Pas, H.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (04) : E71 - E72
  • [6] A Chinese case of concurrent anti-laminin γ1 pemphigoid and anti-laminin 332-type mucous membrane pemphigoid
    Liu, Weijun
    Sun, Xiaoming
    Gao, Yangmin
    Li, Huicheng
    Shi, Luhuai
    Cheng, Lifang
    Zhou, Zhijun
    Li, Xiaoguang
    Qian, Hua
    JOURNAL OF DERMATOLOGY, 2023, 50 (02): : e69 - e71
  • [7] A novel mouse model for anti-laminin 332 mucous membrane pemphigoid
    Heppe, E. N.
    Tofern, S.
    Schulze, F. S.
    Ishiko, A.
    Zillikens, D.
    Goletz, S.
    Schmidt, E.
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (03) : E39 - E39
  • [8] Treatment-refractory anti-laminin 332 mucous membrane pemphigoid
    Recke, A.
    Shimanovich, I.
    Steven, P.
    Westermann, L.
    Zillikens, D.
    Schmidt, E.
    HAUTARZT, 2011, 62 (11): : 852 - +
  • [9] Therapeutic effect of etanercept in anti-laminin 5 (laminin 332) mucous membrane pemphigoid
    Schulz, Sarah
    Deuster, Dirk
    Schmidt, Enno
    Bonsmann, Gisela
    Beissert, Stefan
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2011, 50 (09) : 1129 - 1131
  • [10] Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
    Goletz, Stephanie
    Giurdanella, Federica
    Holtsche, Maike M.
    Nijenhuis, Miranda
    Horvath, Barbara
    Diercks, Gilles F. H.
    Zillikens, Detlef
    Hashimoto, Takashi
    Schmidt, Enno
    Pas, Hendri H.
    FRONTIERS IN IMMUNOLOGY, 2021, 12